Literature DB >> 12831061

A computer algorithm describing the process of vessel formation and maturation, and its use for predicting the effects of anti-angiogenic and anti-maturation therapy on vascular tumor growth.

L Arakelyan1, V Vainstein, Z Agur.   

Abstract

We put forward an algorithm describing the three principal interconnected sub-processes that influence tumor and vasculature dynamics: (i) tumor cell proliferation (ii) angiogenesis, that is, the formation and regression of immature vessels (IV), and (iii) maturation, i.e., the formation and destabilization of mature vessels (MV). This algorithm takes account of the crucial quantitative interactions of these sub-processes, occurring across the molecular, cellular and organ levels. Implementing this complex algorithm in a computer model, one can evaluate the correlations between various factors influencing angiogenesis and their influence on tumor progression at any given moment. Moreover, the computer simulations enable analysis of the versatile effects of drugs on the growth and decay of both the tumor and the immature and mature blood vessels, as well as on the induction of an array of relevant growth factors such as angiopoietin-1 (Ang1), angiopoietin-2 (Ang2), vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF). Simulation results suggest that vessel maturation and destabilization of MV drive the otherwise non-linearly growing system into a very dynamic region, having irregular, scale-invariant, fluctuations, around certain asymptotic values of all the involved quantities. Destabilization itself adequately explains the experimentally observed eventual decrease of tumor growth, with no need to implicate additional assumptions, such as a new tumor growth inhibitory, or anti-angiogenic, factors. Our results further suggest that mono-therapy alone can slow tumor growth, but is not capable of eliminating it altogether. In contrast, the combined treatment of anti-angiogenic and anti-maturation drugs causes prolonged suppression of tumor growth and a significant linear decrease in average tumor size. Laboratory experiments are warranted for validating our predictions and for providing in vivo evaluated parameters.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12831061     DOI: 10.1023/a:1023841921971

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  22 in total

Review 1.  Systems biology of the microvasculature.

Authors:  Lindsay E Clegg; Feilim Mac Gabhann
Journal:  Integr Biol (Camb)       Date:  2015-04-02       Impact factor: 2.192

Review 2.  Harnessing systems biology approaches to engineer functional microvascular networks.

Authors:  Lauren S Sefcik; Jennifer L Wilson; Jason A Papin; Edward A Botchwey
Journal:  Tissue Eng Part B Rev       Date:  2010-06       Impact factor: 6.389

Review 3.  Manipulating the microvasculature and its microenvironment.

Authors:  Laxminarayanan Krishnan; Carlos C Chang; Sara S Nunes; Stuart K Williams; Jeffrey A Weiss; James B Hoying
Journal:  Crit Rev Biomed Eng       Date:  2013

4.  Oscillatory dynamics in a model of vascular tumour growth--implications for chemotherapy.

Authors:  I J Stamper; M R Owen; P K Maini; H M Byrne
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

5.  Predicting outcomes of prostate cancer immunotherapy by personalized mathematical models.

Authors:  Natalie Kronik; Yuri Kogan; Moran Elishmereni; Karin Halevi-Tobias; Stanimir Vuk-Pavlović; Zvia Agur
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

Review 6.  Mathematical modeling as a tool for planning anticancer therapy.

Authors:  Andrzej Swierniak; Marek Kimmel; Jaroslaw Smieja
Journal:  Eur J Pharmacol       Date:  2009-10-13       Impact factor: 4.432

7.  Angiogenesis and vascular remodelling in normal and cancerous tissues.

Authors:  Markus R Owen; Tomás Alarcón; Philip K Maini; Helen M Byrne
Journal:  J Math Biol       Date:  2008-10-22       Impact factor: 2.259

8.  Efficacy of weekly docetaxel and bevacizumab in mesenchymal chondrosarcoma: a new theranostic method combining xenografted biopsies with a mathematical model.

Authors:  Boris Gorelik; Irit Ziv; Revital Shohat; Michael Wick; W David Hankins; David Sidransky; Zvia Agur
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

Review 9.  Computational and mathematical modeling of angiogenesis.

Authors:  Shayn M Peirce
Journal:  Microcirculation       Date:  2008-11       Impact factor: 2.628

10.  Computational systems biology in cancer: modeling methods and applications.

Authors:  Wayne Materi; David S Wishart
Journal:  Gene Regul Syst Bio       Date:  2007-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.